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Background: Triple assessment has been recommended in diagnosis of Breast cancer in Uganda. 
This review analyses its diagnostic value in patients presenting with clinically malignant breast 
lumps.  
Objective: To establish the validity and reliability of the triple assessment in the pre-operative 
evaluation of patients with breast cancer in Mulago Hospital.                                                      
Methods: A total of 200 patients suspected to have breast cancer were evaluated. All patients 
underwent clinical evaluation, mammography and fine needle aspiration cytology. Histology was 
done to confirm the diagnosis.                                                                                                             
Results: A total of 200 patients were studied. The age ranged from 19 to 88 years. Sixty-six patients 
had benign lesions. There were 134 were breast cancer cases. With triple assessment, 84 patients 
were diagnostic for malignancy and 30 benign, respectively confirmed by histology. The Sensitivity, 
Specificity, Positive Predictive Value, Negative Predictive Value and Accuracy were respectively 
100.0%. Error was 0.0%. The Kappa statistic for the combination was 1.0.                            
Conclusions and Recommendations: The triple assessment is valid and reliable. Breast masses can be 
diagnosed with a high degree of accuracy by the triple assessment. Diagnostic open biopsy is 
mandated if the triple assessment results show a lack of concordance.  
Introduction 
In UK and USA, the incidence of Breast cancer is 
80-100:100,000. In Africa, the incidence is 
reported as 13-16 per 100,000 women3. In 
Uganda, the incidence has doubled from 
11:100,000 in 1961 to 22:100,000 in 1995 and has 
become third commonest malignancy, after cancer 
of the cervix and Kaposi’s sarcoma4,5. In 2003, 
Mulago Hospital, breast clinic registered 670 new 
patients; 15-20% of them had malignancy6,7. More 
than 75% of the patients with breast cancer 
present late6.  
The Breast Cancer Guidelines for Uganda 
recommends diagnosis of breast lumps by a triple 
assessment using minimally invasive procedures 
before definitive treatment8. At the breast clinic in 
Mulago Hospital, the patients undergo routine 
clinical evaluation and are investigated by 
mammography and fine needle aspiration 
cytology (FNAC) in the triple assessment. Open 
biopsy is still in common practice as a diagnostic 
procedure, but it is invasive and risks escalating 
spread of malignancy. Mammography and FNAC 
though not conclusive, have been evaluated 
locally and the findings are valid and reliable9,10.  
 
The triple assessment has been routinely practiced 
in the developed world since its earliest 
evaluation11,12.  
The validity and reliability of the triple 
assessment in Uganda is not known, as no local 
studies have been done. Locally generated 
information is necessary to strengthen the national 
guidelines and influence health service planning 
to increase availability and access to the 
diagnostic facilities. 
The aim of this study was to determine the 
validity and reliability of the triple assessment in 
the pre-operative evaluation of patients with 
breast cancer in Mulago Hospital. Specifically the 
objectives were to evaluate the diagnostic 
outcome of clinical assessment, mammography 
and FNAC in isolation and when combined, using 
histology as the gold standard. 
Patients and Methods 
A cross-sectional study was undertaken in Mulago 
Hospital between January 2003 and April 2004. 
The Study Population was comprised of the new 
patients attending the breast clinic and those 
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admitted in the general surgical wards with breast 
lesions clinically suspected to cancerous. All 
patients aged 18 years and above who presented 
with suspected breast cancer consented to 
participate in the study were included in the study. 
Patients with recurrent breast cancer on the same 
side and those with ulcerated breast masses 
difficult to compress at mammography, were 
excluded.  
Using the method of fixed numbers13,14 200 
consecutive patients were recruited. All the 
patients underwent clinical evaluation, 
mammography and FNAC. Histology was done to 
confirm the diagnoses. Ethical considerations 
included seeking of permission to carry out the 
study from appropriate authorities and 
confidentiality 
All the subjects were interviewed and examined 
by the Principal Investigator who also did the 
FNAB. Clinical evaluation included the patients’ 
demographic details, history of breast disease and 
physical examination. Physical findings 
suggestive of breast cancer were hard irregular 
lumps, nipple elevation and retraction, areola 
thickening, peau d’orange, skin tethering and 
erythema, axillary lymphadenopathy. Regular 
mobile masses were considered benign. At 
mammography standard cranio-caudal and 
oblique views were taken. The radiologist’s 
findings and report were recorded as the 
radiological diagnosis.  
 
FNAB was taken from the lesion following 
aseptic procedure using 23G needle and 5ml 
syringe. Two slides of thin films were made and 
stained with a standard haematoxylin and eosin. 
The pathologist’s report was recorded as the 
cytological diagnosis. The clinical, mammography 
and FNAC diagnoses were respectively coded as:  
1. Normal.  
2. Benign. 
3. Equivocal.  
4. Indeterminate, suspicious of malignancy.  
5. Malignant.  
 
Biopsies were taken from specimens removed 
after therapeutic surgery, diagnostic surgery or 
core needle biopsy in case of patients who 
declined surgery or those with inoperable disease. 
The histological report was coded as: 
1. Benign. 
2. Malignant.  
 
Definitive treatment was started when the three 
diagnostic procedures concurred. In cases of 
diagnostic discrepancy, a core biopsy was 
obtained from large tumours and wide excision 
biopsy done for small tumours of up to 3cm in 
size. Histology guided the subsequent 
modifications in treatment.  
 
Data was collected by a pre-tested questionnaire, 
coded and entered in SPSS version 10.0 statistical 
software for analysis. Variables were cross-
tabulated against histology, the gold standard. The 
sensitivity, specificity, accuracy, Positive 
Predictive Value (PPV) and Negative Predictive 
Value (NPV), accuracy and error were determined 
for the individual methods and when 
combined15,16. A p-value obtained for each 
observation was considered significant if found 
less than 0.05.  
The Kappa statistic was calculated for individual 
methods and their combination. A value above 
0.75 suggested excellent agreement with 
histology, 0.40 to 0.75 was intermediate to good 
agreement and below 0.40 suggested poor 
agreement13,17. 
Results 
Out of the 200 patients recruited in the study, 194 
(97.0%) were female and 6 were males. Their 
ages ranged from 19 to 88 with a mean of 48.0 
years (p-value = 0.017).  
 
A third of the patients (33%) had histologically 
benign disease. Histology confirmed a diagnosis 
of breast cancer in 134 (67%) of the cases. Among 
them 131 (97.8%) were females.  
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Table 1. Level of Concurrence of the Triple Assessment compared with Histology. 
 
 Key:    
M: Malignant;  
 I: Indeterminate; suspicious;              
not diagnostic;   
B: Benign 
Mamog: Mammography.  
 FNAC: Fine Neddle 
Aspiration Cytology.           
Triple: Triple Assessment.  




Table 2. Summary of Evaluation of Diagnostic Methods for Breast Cancer 
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Malignant 21 133 154         
Total 66 134 200  99.3 68.2 86.4 97.8 89.0 11.0 0.73 
            
Histology         Mamog 
B M 
T  















Malignant 1 98 99         
Total 66 134 200  73.1 98.5 99.0 64.4 81.5 18.5 0.63 
            
Histology         FNAC 
B M 
T  















Malignant 1 99 100         
Total 66 134 200  73.9 98.5 99.0 65.0 82.0 18.0 0.64 
            
Histology         Triple  
B M 
T  















Malignant 0 84 84         





Diagnosis Mammography FNAC 
Malignant Benign 
Total 
1 M M M 84 0 84 
2 M M I 8 0 8 
3 M M B 6 1 7 
4 M I M 13 0 13 
5 M I I 4 3 7 
6 M I B 9 7 16 
7 M B M 2 1 3 
8 M B I 3 2 5 
9 M B B 5 7 12 
10 B I I 0 4 4 
11 B I B 0 9 9 
12 B B I 0 2 2 
13 B B B 0 30 30 
Total 134 66 200 
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Three breast cancer patients were males; giving a 
female to male ratio of approximately 44:1 among 
those found to have breast cancer (p-value = 
0.369).  
On examination, 71.5% of the patients were in 
good general condition – Kanorfsky scale above 
70% (p-value = 0.000). Clinically, 154 patients 
were diagnosed malignant of who 133 was True 
Positive. Forty-five of the 46 diagnosed have 
benign lesions were True Negative (p-value = 
0.000). The Sensitivity and specificity of Clinical 
examination was 99.3% and 68.2% respectively. 
The Positive Predictive Value was 86.4%. The 
Error was 11.0% and Kappa statistic 0.73. From 
mammography, 98 patients out 99 were True 
Positive. 65 patients out of 101 were True 
Negative (p-value = 0.000). The Sensitivity was 
73.1% and Specificity 98.5%. The Positive 
Predictive Value was 99.0%. Error was 18.5% and 
Kappa statistic 0.63. 
From FNAC, 99 out of 100 patients were True 
Positive. 65 patients out of 100 were True 
Negative (p-value = 0.000). The Sensitivity was 
73.9%, Specificity 98.5% and Positive Predictive 
Value was 99.0%.  
Error was 18.0% and the Kappa statistic 0.64.In 
the triple assessment, 84 and 30 patients were 
respectively confirmed by histology to have 
malignancy and benign disease (p-value = 0.000). 
The Sensitivity, Specificity, Positive Predictive 
Value, Negative Predictive Value and Accuracy 
were respectively 100.0%. Error was 0.0%. The 
Kappa statistic for the combination was 1.0. 
Table 1 shows the level of agreement of the 
diagnostic tests and Table 2 shows the findings of 
the tests compared with histology. 
Discussion 
The registration showed evidence of rising 
numbers of new patients at the breast clinic.  On 
average, 2 new patients were diagnosed with 
breast cancer per week. Clinical evaluation of the 
patients showed high sensitivity (99.3%), and 
relatively moderate specificity (68.2%) and high 
error (11.0%). There was good agreement with 
histology (κ = 0.73). False positive diagnoses 
resulted from the high index of suspicion and 
prudence towards breast lumps. False negative 
clinical diagnoses arose from atypical 
presentations commonly seen among patients 
below 30 years. Diagnosis of breast cancer was 
straightforward with advanced disease. The 
findings were compatible with findings of other 
studies10, 18, 19, 20, 21, 22,23.  
 
On mammography there was moderate sensitivity 
(73.1%), high specificity (98.5%), high PPV 
(99.0%) and high error (18.5%). There was 
moderate agreement with histology (κ=0.64). A 
variety of radiological patterns were seen at 
mammography. Definitive diagnoses were made 
from hard lumps, which produced stellate, or 
spiculated appearances. False negative or 
indeterminate diagnoses were from soft, cystic or 
ill-defined lumps, and lumps close to chest wall. 
With improved technology and experience a high 
specificity is expected from mammography. These 
observations are consistent with findings in local 
and international studies7,10,16-21, 24,-27 
 
FNAC showed moderate sensitivity (73.9%), high 
specificity (99.5%), high PPV (99.0%) and high 
error (18.0%). False positive diagnoses were very 
minimal. False negative and inconclusive reports 
were seen from acellular aspirates from very hard 
lumps, haemorrhagic aspirates from highly 
vascular tumours and aspirates from cystic lumps. 
There was moderate agreement with histology 
(κ=0.64). Other studies showed similar findings. 
8,16-21,25, 26,22,23,24,25, 
On combination (The Triple Assessment) the 
methods concurred in 57% (114) of all patients. 
Concurrence was observed in similar proportions 
form other studies.10,16,21 When methods concurred 
there were no false positive and false negative 
findings. There was 100% sensitivity, specificity 
and accuracy 100%. Kappa statistic (κ) was 1.0 
implying excellent agreement with histology. 
Similar observations of improved sensitivity, 
specificity and accuracy on the combined 
diagnostic methods were made in other studies. 
From the combination errors of individual 
methods get mutually cancelled and a definitive 
diagnosis was made with confidence, a view held 
by Kreuzer. The high errors of cytology and 
mammography limit their isolated10,16-20, 27, 28 29  
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Among the discordant results when two of the 
methods diagnosed malignancy, 93.5% were 
confirmed and when at least one method 
diagnosed malignancy 70% of them were 
confirmed. This suggested that if malignancy was 
one of the three diagnoses it could be upheld as 
further diagnostic evaluations are done. The 
concept of upholding the worst diagnosis is 
recommended by the breast cancer guidelines for 
Uganda.5 
Conclusions and Recommendations 
Clinical diagnosis of breast cancer is of higher 
sensitivity than specificity and has high diagnostic 
error. Mammography and FNAC respectively 
have lower sensitivity than specificity but have 
high positive predictive values. When combined 
in the triple assessment, a definitive diagnosis can 
be made when the diagnoses concur, suggesting 
that the triple assessment has a high sensitivity, 
specificity, positive predictive value and negative 
predictive value with minimal error and excellent 
Kappa statistic. The output of the triple 
assessment in reproducible, making it a valid and 
reliable diagnostic approach to diagnosis of breast 
cancer.  
It is recommended that triple assessment should 
be practiced as the standard diagnostic method to 
diagnose of breast cancer. Definitive treatment 
can be started from diagnosis by the triple 
assessment before histology. The role of other 
radiological methods e.g. ultrasonography in the 
triple assessment should It is recommended that 
the triple assessment be evaluated to widen its 
scope and reduce its cost as a valid and reliable 
diagnostic method. 
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